Various research efforts, including molecular profiling of specific cancer types, have provided insights into the potential correlation between IL-20 subfamily members’ expression profiles and disease outcomes, such as disease-free survival and clinicopathological factors [45]. This evidence concerns the gene IL20 and cancer.